Patients & Caregivers divider SITE MAP divider CONTACT US divider HOME
Sinus Image education center image
 
 
 
Treatment Options for CRS

Topical medications can be delivered to the sinuses using several methods. Some of these, including spray bottles and nebulizers, may already be familiar to patients, especially those patients also being treated for asthma or allergies. Other methods include atomizers and bulb syringes.

Most patients with chronic rhinosinusitis (CRS) who receive treatment with topical antifungals will use a bulb syringe. This is the method found to be most effective for this therapy as described in the study below.

As with all medications, you should carefully follow instructions for administering the drug. It is very important that you use your medication exactly as directed by your doctor.

To help you remember when to use your medication, it is helpful to use it at the same time every day. One suggestion is to use the medication right before or right after you do something else, such as brushing your teeth.

If you have any questions about the medication or using the bulb syringe, talk to your doctor, pharmacist, or other health care professional. You can also download the "Instructions for Using the Bulb Syringe," in the related materials section on the left, to supplement the instructions you receive from your healthcare team.

Clinical Studies

  • Comparison of Topical Medication Delivery Systems after Sinus Surgery
    Proper drug distribution is an important factor in effective treatment of CRS. This article describes a study comparing the delivery of medication using a spray bottle, atomizer, nebulizer, and bulb syringe. Drug distribution varied between delivery systems. The bulb syringe was found to be most effective in delivering medication to the sinuses of patients being treated for CRS.

    For more information, the complete citation for this study is: Miller TR, Muntz HR, Gilbert ME, et al. Comparison of topical medication delivery systems after sinus surgery. Laryngoscope. 2004;114(2):201-4.



TEAMM PHARMACEUTICALS LOGO This site is supported by Accentia Pharmaceuticals, an Accentia Biopharmaceuticals Company. The content was developed in collaboration with Mayo Clinic. For more information visit the Accentia and Mayo Clinic websites.

Copyright © 2004 Accentia Pharmaceuticals.
Privacy Statement Legal Disclaimer